# DermAvance Pharmaceuticals, Inc. – FDA Inspection, Jul 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/dermavance-pharmaceuticals-inc/aa82b371-b8b9-49ec-a1b7-9e2f1b51bdae
Source feed: FDA_Inspections

> FDA inspection 1059220 of DermAvance Pharmaceuticals, Inc., July 17, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 812. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059220
- Company Name: DermAvance Pharmaceuticals, Inc.
- Inspection Date: 2018-07-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Officers

- [Joseph L. Despins](https://www.keypedia.com/people/joseph-l-despins/c84402a8-7ebb-45ab-b1b9-c43a143c5fb8)

Company: https://www.keypedia.com/companies/dermavance-pharmaceuticals-inc/fd276aaf-86f4-43f8-b96d-6a5b9515ea7b

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7